Discussion about this post

User's avatar
Suzanne Vyvoda's avatar

I felt this deeply. The turning point for me came after an acquisition paused multiple programs and reshaped entire teams. What started as a setback became a catalyst — opening the door to fractional and consulting work across biotech. In today’s market, that shift isn’t just reactive; it’s how many of us are continuing to build, lead, and deliver impact even as the landscape keeps changing.

Expand full comment
1 more comment...

No posts